[1]
|
单姗, 赵连晖, 马红, 欧晓娟, 尤红, 贾继东. 肝硬化的定义、病因及流行病学[J]. 临床肝胆病杂志, 2021, 37(1): 14-16.
|
[2]
|
Ginés, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., Caballería, J., Rodés, J. and Roz-man, C. (1987) Compensated Cirrhosis: Natural History and Prognostic Factors. Hepatology, 7, 122-128.
https://doi.org/10.1002/hep.1840070124
|
[3]
|
朱龙川, 甘达凯, 胡青青, 熊墨龙. 第三代头孢菌素耐药的自发性细菌性腹膜炎发生的预测因素[J]. 临床肝胆病杂志, 2019, 35(7): 1501-1504.
|
[4]
|
Aljumah, A.A., Selayem, N.B., Al-Howti, S.Y., Dafallah, M., AlGhamdi, H., Mokhtar, H., et al. (2018) Clinical and Virological Outcomes of Entecavir Therapy in Patients with Chronic Hepatitis B: A Real Life Experience. Journal of Infection and Chemotherapy, 25, 12-16. https://doi.org/10.1016/j.jiac.2018.09.014
|
[5]
|
Singal, A.K., Salameh, H. and Kamath, P.S. (2014) Prevalence and In-Hospital Mortality Trends of Infections among Patients with Cirrhosis: A Nationwide Study of Hospitalized Patients in the United States. Alimentary Pharmacology & Therapeutics, 40, 105-112. https://doi.org/10.1111/apt.12797
|
[6]
|
Tay, P.W.L., Xiao, J., Tan, D.J.H., Ng, C., Lye, Y.N., Lim, W.H., et al. (2021) An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis. Frontiers in Medicine, 8, Article ID: 693652. https://doi.org/10.3389/fmed.2021.693652
|
[7]
|
Wang, Y. and Zhang, Q. (2018) Analysis of Risk Factors for Pa-tients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis. Iranian Journal of Public Health, 47, 1883-1890.
|
[8]
|
Marciano, S., Díaz, J.M., Dirchwolf, M. and Gadano, A. (2019) Spontaneous Bacterial Peritonitis in Patients with Cirrhosis: Incidence, Outcomes, and Treatment Strategies. Hepatic Medicine: Evidence and Research, 11, 13-22.
https://doi.org/10.2147/HMER.S164250
|
[9]
|
申红霞, 娄小平, 苌新伟, 郑晓, 杜文婷, 赵贝贝, 王文娟. 肝硬化患者自发性细菌性腹膜炎危险因素的Meta分析[J]. 世界华人消化杂志, 2016, 24(12): 1903-1909.
|
[10]
|
倪传斌, 陈武军. 80例肝硬化腹水并发自发性细菌性腹膜炎高危因素分析[J]. 中国热带医学, 2013, 13(12): 1514-1516
|
[11]
|
冯梦蝶. 肝硬化合并自发性细菌性腹膜炎27例高危因素分析[J]. 海南医学, 2012, 23(13): 72-74.
|
[12]
|
Thomson, M.J., Tapper, E.B. and Lok, A.S. (2018) Dos and Don’ts in the Management of Cirrhosis: A View from the 21st Centu-ry. American Journal of Gastroenterology, 113, 927-931. https://doi.org/10.1038/s41395-018-0028-5
|
[13]
|
Granito, A. and Bolondi, L. (2017) Non-Transplant Therapies for Patients with Hepatocellular Carcinoma and Child-Pugh-Turcotte Class B Cirrhosis. Lancet Oncology, 18, E101-E112.
https://doi.org/10.1016/S1470-2045(16)30569-1
|
[14]
|
黎倍伶, 钟国涛, 陈金军. 自发性细菌性腹膜炎诊断和治疗现状[J]. 临床肝胆病杂志, 2019, 35(9): 2079-2081.
|
[15]
|
邓媛, 廖毅. 慢性肝炎肝硬化腹水并发自发性细菌性腹膜炎相关危险因素分析[J]. 中国基层医药, 2011, 18(16): 2182-2183
|
[16]
|
Huang, C.H., Lin, C.Y., Sheen, I.S., Chen, W.-T., Lin, T.-N., Ho, Y.-P., et al. (2011) Recurrence of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Non Prophylactically Treated with Norfloxacin: Serum Albumin as an Easy but Reliable Predictive Factor. Liver Interna-tional, 31, 184-191. https://doi.org/10.1111/j.1478-3231.2010.02377.x
|
[17]
|
Lee, S., Saxinger, L., Ma, M., Prado, V., Fernández, J., Kumar, D., et al. (2017) Bacterial Infections in Acute Variceal Hemorrhage Despite Antibiotics—A Multicenter Study of Predictors and Clinical Impact. United European Gastroenterology Journal, 5, 1090-1099. https://doi.org/10.1177/2050640617704564
|
[18]
|
武瑞, 刘春涛, 傅晓晴, 刘寿荣. 非选择性β-受体阻滞剂对失代偿肝硬化患者循环及肾损伤的影响研究[J]. 中国现代医生, 2018, 56(25): 5-9.
|
[19]
|
Gyu, J.B., Cheul, L.W., Young, J.J., Jeong, S.W., Kim, Y.D., Cheon, G.J., et al. (2018) Follow-up Creatinine Level Is an Important Predictive Factor of In-Hospital Mortality in Cirrhotic Patients with Spontaneous Bacterial Peritonitis. Journal of Korean Medical Science, 33, e99. https://doi.org/10.3346/jkms.2018.33.e99
|
[20]
|
Schrier, R.W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J.H. and Rodés, J. (1998) Peripheral Arterial Vasodilation Hypothesis: A Proposal for the Initiation of Renal Sodium and Water Retention in Cirrhosis. Hepatology, 8, 1151-1157. https://doi.org/10.1002/hep.1840080532
|
[21]
|
Fasolato, S., Angeli, P., Dallagnese, L., Maresio, G., Zola, E., Mazza, E., et al. (2010) Renal Failure and Bacterial Infections in Patients with Cirrhosis: Epidemiology and Clinical Features. Hepatology, 45, 223-229.
https://doi.org/10.1002/hep.21443
|
[22]
|
Follo, A., Llovet, J.M., Navasa, M., Planas, R., Forns, X., Francitorra, A., et al. (1994) Renal Impairment after Spontaneous Bacterial Peritonitis in Cirrhosis: Incidence, Clinical Course, Predictive Factors and Prognosis. Hepatology, 20, 1495-1501. https://doi.org/10.1002/hep.1840200619
|
[23]
|
Tandon, P. and Garcia-Tsao, G. (2011) Renal Dysfunction is the Most Important Independent Predictor of Mortality in Cirrhotic Patients with Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology, 9, 260-265.
https://doi.org/10.1016/j.cgh.2010.11.038
|
[24]
|
Imhann, F, Bonder, M.J., Vila, A.V., Fu, J., Mujagic, Z., Vork, L., et al. (2016) Proton Pump Inhibitors Affect the Gut Microbiome. Gut, 65, 740-748. https://doi.org/10.1136/gutjnl-2015-310376
|
[25]
|
Brandl, K. and Schnabl, B. (2015) Is Intestinal Inflammation Linking Dysbiosis to Gut Barrier Dysfunction during Liver Disease? Expert Review of Gastroenterology & Hepatology, 9, 1069-1076.
https://doi.org/10.1586/17474124.2015.1057122
|
[26]
|
Bajaj, J.S., Chathur, A., Andrew, F., White, M.B., Gavis, E., Heuman, D.M., et al. (2018) Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis. American Journal of Gastroenterology, 113, 1177-1186. https://doi.org/10.1038/s41395-018-0085-9
|
[27]
|
European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis. Journal of Hepatology, 69, 406-460. https://doi.org/10.1016/j.jhep.2018.03.024
|
[28]
|
Komolafe, O., Roberts, D., Freeman, S.C., Wilson, P., Sutton, A.J., Cooper, N.J., Pavlov, C.S., Milne, E.J., Hawkins, N., Cowlin, M., Thorburn, D., Davidson, B.R., Tsochat-zis, E. and Gurusamy, K.S. (2020) Antibiotic Prophylaxis to Prevent Spontaneous Bacterial Peritonitis in People with Liver Cirrhosis: A Network Meta-Analysis. Cochrane Database of Systematic Reviews, Article No. CD013125. https://doi.org/10.1002/14651858.CD013125.pub2
|
[29]
|
Li, Y.-T., Yu, C.-B., Huang, J.-R., Qin, Z.-J. and Li, L.-J. (2015) Pathogen Profile and Drug Resistance Analysis of Spontaneous Peritonitis in Cirrhotic Patients. World Journal of Gastroenterology, 21, 10409-10417.
https://doi.org/10.3748/wjg.v21.i36.10409
|
[30]
|
Ding, X., Yu, Y.H., Chen, M., Wang, C., Kang, Y.F. and Lou, J.L. (2019) Causative Agents and Outcome of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: Community-Acquired versus No Socomial Infections. BMC Infectious Diseases, 19, Article No. 463. https://doi.org/10.1186/s12879-019-4102-4
|
[31]
|
Campillo, B., Dupeyron, C. and Richardet, J.P. (2001) Epidemi-ology of Hospital-Acquired Infections in Cirrhotic Patients: Effect of Carriage of Methicillin-Resistant Staphylococcus aureus and Influence of Previous Antibiotic Therapy and Norfloxacin Prophylaxis. Epidemiology & Infection, 127, 443-450. https://doi.org/10.1017/S0950268801006288
|
[32]
|
Fiore, M., Gentile, I., Maraolo, A.E., Leone, S., Sim-eon, V., Chiodini, P., et al. (2018) Are Third-Generation Cephalosporins Still the Empirical Antibiotic Treatment of Community-Acquired Spontaneous Bacterial Peritonitis? A Systematic Review and Meta-Analysis. European Journal of Gastroenterology & Hepatology, 30, 329-336.
https://doi.org/10.1097/MEG.0000000000001057
|
[33]
|
Campillo, B., Dupeyron, C., Richardet, J.P., Mangeney, N. and Leluan, G. (1998) Epidemiology of Severe Hospital-Acquired Infections in Patients with Liver Cirrhosis: Effect of Long-Term Administration of Norfloxacin. Clinical Infectious Diseases, 26, 1066-1070. https://doi.org/10.1086/520273
|
[34]
|
Lutz, P., Nischalke, H.D., Krämer, B., Goeser, F., Kaczmarek, D.J., Schlabe, S., et al. (2017) Antibiotic Resistance in Healthcare-Related and Nosocomial Spontaneous Bacterial Peritonitis. European Journal of Clinical Investigation, 47, 44-52. https://doi.org/10.1111/eci.12701
|
[35]
|
Rostkowska, K.A., Szy-manek-Pasternak, A. and Simon, K.A. (2018) Spontaneous Bacterial Peritonitis—Therapeutic Challenges in the Era of Increasing Drug Resistance of Bacteria. Clinical & Experimental Hepatology, 4, 224-321.
https://doi.org/10.5114/ceh.2018.80123
|
[36]
|
Piano, S., Fasolato, S., Salinas, F., Romano, A., Tonon, M., Morando, F., et al. (2016) The Empirical Antibiotic Treatment of Nosocomial Spontaneous Bacterial Peritonitis: Results of a Ran-domized, Controlled Clinical Trial. Hepatology, 63, 1299-1309. https://doi.org/10.1002/hep.27941
|
[37]
|
Tariq, T., Irfan, F.B., Farishta, M., Dykstra, B., Sieloff, E.M. and Desai, A.P. (2019) Spontaneous Fungal Peritonitis: Mi-cro-Organisms, Management and Mortality in Liver Cirrhosis—A Systematic Review. World Journal of Hepatology, 11, 596-606. https://doi.org/10.4254/wjh.v11.i7.596
|
[38]
|
Liang, S., Webb, T. and Li, Z. (2014) Probiotic Antigens Stimulate Hepatic Natural Killer T Cells. Immunology, 141, 203-210. https://doi.org/10.1111/imm.12180
|
[39]
|
Macnaughtan, J., Figorilli, F., García-López, E., Lu, H., Jones, H., Sawhney, R., et al. (2020) A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shi-rota in Stable Cirrhotic Patients. Nutrients, 12, Article No. 1651. https://doi.org/10.3390/nu12061651
|
[40]
|
Sánchez, E., Nieto, J.C., Vidal, S., Santiago, A., Martinez, X., Sancho, F.J., et al. (2017) Fermented Milk Containing Lactobacil-lus paracasei subsp. paracasei CNCM I-1518 Reduces Bacterial Translocation in Rats Treated with Carbon Tetrachlo-ride. Scientific Reports, 7, Article No. 45712. https://doi.org/10.1038/srep45712
|
[41]
|
Pande, C., Kumar, A. and Sarin, S.K. (2012) Addition of probiotics to norfloxacin does not improve efficacy in the Prevention of Spontaneous Bacterial Peritonitis: A Double-Blind Placebo-Controlled Randomized-Controlled Trial. European Journal of Gastroen-terology & Hepatology, 24, 831-839. https://doi.org/10.1097/MEG.0b013e3283537d61
|
[42]
|
Mücke, M.M., Mücke, V.T., Graf, C., et al. (2020) Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A System-atic Review and Meta-Analysis. Clinical and Translational Gastroenterology, 11, Article No. e00223. https://doi.org/10.14309/ctg.0000000000000223
|
[43]
|
Ginès, P., Tito, L.V., Arroyo, V., Planas, R., Panés, J., Viver, J., et al. (1988) Randomized Comparative Study of Therapeutic Paracentesis with and without Intravenous Albumin in Cirrhosis. Gastroenterology, 94, 1493-1502.
https://doi.org/10.1016/0016-5085(88)90691-9
|
[44]
|
Sort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruiz-del-Arbol, L., et al. (1999) Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cir-rhosis and Spontaneous Bacterial Peritonitis. The New England Journal of Medicine, 341, 403-409. https://doi.org/10.1056/NEJM199908053410603
|
[45]
|
Shalaby, S.M., Baiumy, E.M., Abdelrahman, M.G., Sayed, M.M., Abdelhalim, R.M. and Amer, A.A. (2020) Assessment of Serum 25-Hydroxy Vitamin D in Cirrhotic Patients with and without Spontaneous Bacterial Peritonitis (SBP). QJM: An International Journal of Medicine, 113, hcaa052.015. https://doi.org/10.1093/qjmed/hcaa052.015
|
[46]
|
Philips, C.A., Pande, A., Shasthry, S.M., Jamwal, K.D., Khillan, V., Chandel, S.S., et al. (2016) Healthy Donor Fecal Microbiota Transplantation in Steroid Ineligible Severe Alcoholic Hepatitis—A Pilot Study. Clinical Gastroenterology and Hepatology, 15, 600-602. https://doi.org/10.1016/j.cgh.2016.10.029
|
[47]
|
Bajaj, J.S., Salzman, N.H., Acharya, C., Sterling, R.K., White, M.B., Gavis, E.A., et al. (2019) Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Ran-domized, Placebo-Controlled Trial. Hepatology, 70, 1690-1703. https://doi.org/10.1002/hep.30690
|
[48]
|
徐元红, 宋传芳, 周志坚, 张杰, 庄彦华. 粪菌移植治疗肝硬化合并细菌性自发性腹膜炎的临床疗效[J]. 牡丹江医学院学报, 2017, 38(1): 56-57+70.
|